Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 35% ± 22% | |
lung | 10 studies | 24% ± 9% | |
eye | 6 studies | 31% ± 14% | |
heart | 4 studies | 20% ± 1% | |
liver | 4 studies | 33% ± 15% | |
pancreas | 3 studies | 30% ± 11% | |
kidney | 3 studies | 21% ± 3% | |
intestine | 3 studies | 23% ± 7% | |
adipose | 3 studies | 21% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2385.25 | 1445 / 1445 | 100% | 30.39 | 183 / 183 |
ovary | 100% | 1634.92 | 180 / 180 | 100% | 29.06 | 430 / 430 |
pancreas | 100% | 1513.08 | 328 / 328 | 100% | 33.55 | 178 / 178 |
prostate | 100% | 2371.39 | 245 / 245 | 100% | 58.61 | 502 / 502 |
stomach | 100% | 2131.01 | 359 / 359 | 100% | 40.33 | 286 / 286 |
uterus | 100% | 2017.13 | 170 / 170 | 100% | 39.53 | 459 / 459 |
breast | 100% | 2402.24 | 459 / 459 | 100% | 48.83 | 1117 / 1118 |
thymus | 100% | 2463.94 | 653 / 653 | 100% | 42.94 | 604 / 605 |
intestine | 100% | 2657.94 | 966 / 966 | 100% | 47.48 | 526 / 527 |
kidney | 100% | 3707.92 | 89 / 89 | 100% | 33.01 | 899 / 901 |
lung | 100% | 1955.66 | 576 / 578 | 100% | 37.98 | 1155 / 1155 |
bladder | 100% | 2052.43 | 21 / 21 | 100% | 40.97 | 502 / 504 |
brain | 100% | 1417.38 | 2631 / 2642 | 100% | 27.96 | 705 / 705 |
liver | 100% | 2148.02 | 226 / 226 | 100% | 27.44 | 404 / 406 |
adrenal gland | 100% | 3314.02 | 258 / 258 | 99% | 32.88 | 228 / 230 |
skin | 100% | 2747.98 | 1809 / 1809 | 98% | 27.63 | 461 / 472 |
adipose | 100% | 1810.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.28 | 29 / 29 |
spleen | 100% | 1898.69 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.16 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.84 | 1 / 1 |
blood vessel | 100% | 1908.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1499.45 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2318.69 | 840 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 26.59 | 75 / 80 |
peripheral blood | 90% | 1601.89 | 835 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071344 | Biological process | diphosphate metabolic process |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0006796 | Biological process | phosphate-containing compound metabolic process |
GO_0045202 | Cellular component | synapse |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004427 | Molecular function | inorganic diphosphate phosphatase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
Gene name | PPA2 |
Protein name | inorganic diphosphatase (EC 3.6.1.1) Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2) Inorganic pyrophosphatase 2 |
Synonyms | HSPC124 |
Description | FUNCTION: Hydrolyzes inorganic pyrophosphate . This activity is essential for correct regulation of mitochondrial membrane potential, and mitochondrial organization and function . . |
Accessions | ENST00000508518.5 ENST00000506815.5 ENST00000509031.5 ENST00000348706.9 [Q9H2U2-3] A0A0C4DGB9 H0Y8X2 ENST00000341695.10 [Q9H2U2-1] D6RAD3 D6R967 ENST00000514209.5 ENST00000432483.6 [Q9H2U2-6] ENST00000510015.5 ENST00000513649.1 H0YAK2 D6RGI1 H0Y9D8 F8W7R6 ENST00000504028.5 ENST00000502596.5 ENST00000354147.7 [Q9H2U2-4] D6RGV9 ENST00000351450.10 ENST00000515567.5 Q9H2U2 |